Diabetes Research and Clinical Practice
Volume 88, Issue 3 , Pages 295-301 , June 2010

Normalization of glucose intolerance in first-degree relatives of patients with type 2 diabetes

  • Mohsen Janghorbani

      Affiliations

    • Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran
    • Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
    • Corresponding Author InformationCorresponding author at: Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran. Tel.: +98 311 2334893; fax: +98 311 6682509.
    • ,
  • Masoud Amini

      Affiliations

    • Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Received 4 December 2009 ,Revised 13 January 2010 ,Accepted 25 January 2010.

References 

  1. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Bennett PH. Transient impaired glucose tolerance in Pima Indians: is it important?. BMJ. 1988;297:1438–1441
  2. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia. 2003;46:3–19
  3. Amini M, Janghorbani M. Diabetes and impaired glucose regulation in first-degree relatives of patients with type 2 diabetes in Isfahan, Iran: prevalence and risk factors. Rev. Diab. Stud. 2007;4:169–176
  4. Li JK, Ng MC, So WY, Chiu CK, Ozaki R, Tong PC, et al. Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus. Diab. Metab. Res. Rev. 2006;22:46–526
  5. de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD, et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA. 2001;285:2109–2113
  6. Eschwege E, Charles MA, Simon D, Thibult N, Balkau B. Reproducibility of the diagnosis of diabetes over a 30-month follow-up: the Paris Prospective Study. Diabetes Care. 2001;24:1941–1944
  7. Vaccaro O, Ruffa G, Imperatore G, Iovino V, Rivellese AA, Riccardi G. Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. Diabetes Care. 1999;22:1490–1493
  8. Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H, et al. Impaired fasting glucose or impaired glucose tolerance: what best predicts future diabetes in Mauritius?. Diabetes Care. 1999;22:399–402
  9. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care. 2000;23:1108–1112
  10. Valdés S, Botas P, Delgado E, Alvarez F, Cadórniga FD. Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study. Diabetes Care. 2007;30:2258–2263
  11. A.J. Hanley, K. Williams, C. Gonzalez, R.BJr. D’Agostino, L.E. Wagenknecht, M.P. Stern, S.M. Haffner, San Antonio Heart Study, Mexico City Diabetes Study, Insulin Resistance Atherosclerosis Study: Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 52 (2003) 463–469.
  12. Forouhi NG, Luan J, Hennings S, Wareham NJ. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990–2000. Diabet. Med. 2007;24:200–207
  13. Magliano DJ, Barr EL, Zimmet PZ, Cameron AJ, Dunstan DW, Colagiuri S, et al. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care. 2008;31:267–272
  14. Alvarsson M, Hilding A, Ostenson CG. Factors determining normalization of glucose intolerance in middle-aged Swedish men and women: a 8-10-year follow-up. Diabet. Med. 2009;26:345–353
  15. Perreault L, Kahn SE, Christophi CA, Knowler WC, Hamman RF Diabetes Prevention Program Research Group. Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care. 2009;32:1583–1588
  16. Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006;368(23):1096–1105
  17. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002;346:393–403
  18. J.L. Chiasson, R.G. Josse, R. Gomis, M. Hanefeld, A. Karasik, Laakso, M. Acarbose, For prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359 (2002) 2072–2077.
  19. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise: the 6-year Malmö feasibility study. Diabetologia. 1991;34:891–898
  20. Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ. Cardiovascular risk factors prior to the development of non-insulin-dependent diabetes mellitus in persons with impaired glucose tolerance: the Hoorn Study. J. Clin. Epidemiol. 1997;50:1003–1009
  21. Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care. 2005;28:902–909
  22. Wong MS, Gu K, Heng D, Chew SK, Chew LS, Tai ES. The Singapore Impaired Glucose Tolerance Follow-Up Study. Diabetes Care. 2003;26:3024–3030
  23. Bourn DM, Williams SM, Mann JI. Distinguishing between persistent and transient impaired glucose tolerance using a prediction model. Diabet. Med. 1992;9:744–748
  24. Motala AA, Omar MAK, Gouws E. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM. Diabetes Care. 1997;20:1101–1107
  25. Wang JJ, Hu G, Lappalainen J, Miettinen ME, Qiao Q, Tuomilehto J. Changes in features of the metabolic syndrome and incipient impaired glucose regulation or type 2 diabetes in a Chinese population. Diabetes Care. 2005;28:448–450
  26. Qiao Q, Keinänen-Kiukaanniemi S, Rajala U, Uusimäki A, Kivelä SL. Risk for diabetes and persistent impaired glucose tolerance among middle-aged Finns. Diab. Res. Clin. Pract. 1996;33:191–198
  27. Chou P, Li CL, Wu GS, Tsai ST. Progression to type 2 diabetes among high-risk groups in Kin-Chen Kinmen. Diabetes Care. 1998;21:1183–1187
  28. Forouhi NG, Luan J, Hennings S, Wareham NJ. Incidence of type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000. Diabet. Med. 2007;24:200–207
  29. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. The natural history of impaired glucose tolerance in the Pima Indians. N. Engl. J. Med. 1988;319:1500–1506
  30. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes. 2003;52:1475–1484
  31. Executive Summary Standard of Medical Care in Diabetes-2008, Diabetes Care 31 (2008) S5–S11.
  32. Janghorbani M, Amini M. Effects of gender and height on the oral glucose tolerance test: the Isfahan Diabetes Prevention Study. Rev. Diabet. Stud. 2008;5:163–170
  33. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care (Suppl. 1) (2003) S5–20.
  34. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972;18:499–502
  35. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults: executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J. Am. Med. Assoc. 285 (2001) 2486–2497.
  36. Yudkin JS, Alberti KGMM, McLarry DG, Swai ABM. Impaired glucose tolerance: is it a risk factor for diabetes or a diagnostic ragbag?. BMJ. 1990;301:379–402
  37. Motala AA, Omar MAK, Gouws E. High risk of progression to NIDDM in South African Indian with impaired glucose tolerance. Diabetes. 1993;42:556–563
  38. Ramaiya KL, Swai ABM, McLarry DG, Alberti KGMM. Improvement in glucose tolerance after one year of follow-up in a Hindu community in Africa. Diab. Res. Clin. Pract. 1990;10:244–255

PII: S0168-8227(10)00048-3

doi: 10.1016/j.diabres.2010.01.025

Diabetes Research and Clinical Practice
Volume 88, Issue 3 , Pages 295-301 , June 2010

Article Tools